Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 5:43 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 01-Apr-24 | Grant | 2,001 | -- | -- | 3% 58.08K to 60.08K | |
| 04-Jan-24 6:11 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-Jan-24 | Grant | 1,900 | -- | -- | 3% 56.18K to 58.08K | |
| 04-Oct-23 5:47 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-Oct-23 | Grant | 2,619 | -- | -- | 5% 53.56K to 56.18K | |
| 06-Jul-23 6:07 PM View: | Alphabet Inc. (GOOG) | 05-Jul-23 | Grant | 2,841 | -- | -- | 32% 8.82K to 11.66K | |
| 06-Jul-23 6:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jul-23 | Grant | 2,541 | -- | -- | 5% 51.02K to 53.56K | |
| 21-Jun-23 5:17 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Jun-23 | Grant | 12,612 | -- | -- | 33% 38.41K to 51.02K | |
| 05-Apr-23 6:02 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Apr-23 | Grant | 2,721 | -- | -- | 8% 35.68K to 38.41K | |
| 05-Jan-23 6:23 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-23 | Grant | 2,483 | -- | -- | 7% 33.2K to 35.68K | |
| 05-Oct-22 9:13 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Oct-22 | Grant | 1,725 | -- | -- | 5% 31.48K to 33.2K | |
| 09-Aug-22 12:37 PM View: | Alphabet Inc. (GOOG) | 03-Aug-22 | Grant | 8,824 | -- | -- | 100% 0 to 8.82K | |
| 06-Jul-22 5:49 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Jul-22 | Grant | 2,224 | -- | -- | 8% 29.25K to 31.48K | |
| 16-Jun-22 8:10 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Jun-22 | Grant | 18,145 | -- | -- | 163% 11.11K to 29.25K | |
| 05-Apr-22 7:22 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Apr-22 | Grant | 2,438 | -- | -- | 28% 8.67K to 11.11K | |
| 05-Jan-22 8:43 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-22 | Grant | 1,040 | -- | -- | 14% 7.63K to 8.67K | |
| 05-Oct-21 8:35 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Oct-21 | Grant | 858 | -- | -- | 13% 6.77K to 7.63K | |
| 22-Apr-21 7:43 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Conversion | 6,250 | -- | -- | 100% 6.25K to 12.5K | |
| 22-Apr-21 7:43 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Conversion | 6,250 | -- | -- | (50%) 12.5K to 6.25K | |
| 19-Apr-21 7:25 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Apr-21 | Grant | 6,250 | -- | -- | 100% 0 to 6.25K | |
| 09-Feb-18 2:01 PM View: | Goldman Sachs Group Inc. (GS) | 07-Feb-18 | Market Sale (Planned) | 10,289 | $259.26 | $2,667,530.00 | (12%) 88.66K to 78.37K | 5% |
| 09-Feb-18 2:01 PM View: | Goldman Sachs Group Inc. (GS) | 07-Feb-18 | Market Sale (Planned) | 1,540 | $258.98 | $398,837.00 | (2%) 78.37K to 76.83K | 5% |
| 02-Feb-18 2:00 PM View: | Goldman Sachs Group Inc. (GS) | 31-Jan-18 | Market Sale (Planned) | 10,289 | $268.72 | $2,764,850.00 | (10%) 100.49K to 90.2K | 8% |
| 02-Feb-18 2:00 PM View: | Goldman Sachs Group Inc. (GS) | 31-Jan-18 | Market Sale (Planned) | 1,540 | $268.82 | $413,978.00 | (2%) 90.2K to 88.66K | 8% |
| 29-Dec-17 6:01 AM View: | Goldman Sachs Group Inc. (GS) | 28-Dec-17 | Payment of Exercise | 32,435 | $255.95 | $8,301,740.00 | (24%) 132.92K to 100.49K | 4% |
| 29-Dec-17 6:01 AM View: | Goldman Sachs Group Inc. (GS) | 28-Dec-17 | Option Exercise | 58,108 | -- | -- | 78% 74.81K to 132.92K | |
| 10-Mar-04 10:00 PM View: | PNM Resources Inc. (PNM) | 10-Mar-04 | Grant | 1,000 | $30.57 | $30,570.00 | 234% 0.43K to 1.43K | 99% |